SUMMARY
The present results challenge the view that macrophage activation leads to a general, non-specific increase of microbicidal activity of these cells. Instead, it was found that the interactions between activated macrophages and micro-organisms are dependent on the kind of activation and the type of target micro-organism.
INTRODUCTION
The phenomenon of cellular immunity has been known for more than eighty years, and is best illustrated by the experiments of Robert Koch in 1882 [1] . When normal guinea pigs are inoculated subcutaneously with a large number of live tubercle bacilli, the wound first closes and apparently heals, but, after about 10 to 14 days, extensive ulceration develops and persists until the animal dies. When a small number of tubercle bacilli are injected intracutaneously the animal's defences can cope with these micro-organisms and it will survive because a state of immunity has developed. When such an animal has recovered and is re-infected with a large number of tubercle bacilli, it will not die. This increased resistance to infection with tubercle bacilli, based on an altered immunity, can be demonstrated with the tuberculin test. When a small amount of an extract of tubercle bacilli (called tuberculin) is applied to the skin, a local inflammatory reaction becomes manifest in two to three days. Histologically, the reaction is characterized by an infiltrate containing lymphocytes and macrophages. This type of response is called a delayed hypersensitivity reaction, because two to three days elapse before the reaction reaches a maximum.
In 1945, Merril Chase [2] was the first to demonstrate that the cellular immunity to tubercle bacilli and the delayed hypersensitivity reaction expressing the altered state of cellular immunity can be transferred from immune guinea pigs to normal animals by lymphocytes but not by serum. Studies by Mackeness [3, 4] and Blanden et al. [5] showed that live Listeria monocytogenes and BCG activate macrophages that express enhanced microbicidal activity against various microorganisms. This state of acquired immunity is called cellular or cell-mediated immunity. Recent research has shown that lymphokines produced and secreted by T4 (helper) lymphocytes are responsible for the activation of macrophages [6] [7] [8] [9] .
In general, it has been assumed that activated macrophages express enhanced microbicidal activity against all types of micro-organism irrespective of the kind of stimulus. In the present paper that view is challenged and it will be shown that activated macrophages exert their increased microbicidal activity only toward certain types of micro-organism depending on the kind of stimulus. In addition, it will be shown that the view that interferon-gamma (IFN-'t) is the only lymphokine [10] that enhances the bactericidal activity of macrophages is not correct.
The role of macrophages in innate immunity
Inbred mouse strains differ in their innate resistance to Salmonella typhimurium. For example, CBA mice are resistant to these bacteria (LDs0 2 × 10 4 S. typhimurium) and C57BL/10 mice are not (LDs0 < 1 X 102 S. typhimurium) [11, 12] . At the onset of an infection, bacteria first encounter resident tissue macrophages, next granulocytes migrating from the circulation to the site of infection, and then exudate macrophages, which are recently immigrated monocytes that differentiate into macrophages. The finding that phagocytosis, followed by intracellular killing of bacteria by granulocytes and macrophages forms one of the most important mechanisms for the elimination of micro-organisms, raised the question as to whether the difference in innate resistance to S. typhimurium is due to a difference in the phagocytosis or intracellular killing of phagocytes from CBA and C57BL/10 mice. Our studies have shown that optimally opsonized S. typhimurium are ingested equally well by resident macrophages, exudate peritoneal cells, and blood granulocytes from both strains [11] [12] [13] . This implies that differences in innate resistance to S. typhimurium cannot be explained by a difference in phagocytosis.
Studies on the intracellular killing of bacteria performed with an in vitro assay after phagocytosis of the bacteria in vivo or in vitro showed that the rates of intracellular killing of S. typhimurium by all three of the above-mentioned categories of phagocyte from CBA mice were significantly higher than those for C57BL/10 mice (Table 1 ) [11] [12] [13] . Before firm conclusions could be drawn from in vitro experiments with isolated cells, in vivo studies on the elimination of bacteria from the circulation and their multiplication in various organs had to be performed. It was found that rates of clearance of S. typhimurium from the blood stream were equal for CBA and C57BL/10 mice [12] . However, the growth rates of S. typhimurium in the spleen and liver of CBA mice were [12, 13] ). ** About 75% of the exudate cells were granulocytes.
significantly lower than those in organs of C57BL/10 mice (Table 2 ) [12] . These in vivo results indicate that elimination of bacteria by ingestion and killing of phagocytes in the spleen and liver is faster in CBA than in C57BL/10 mice, and are thus in agreement with the in vitro results showing differences in rates of intracellular killing between phagocytes of both mouse strains. Taken together, the in vivo and in vitro findings led to the conclusion that the greater resistance of CBA versus C57BL/10 mice to S. typhimurium can be explained by a greater bactericidal activity of the phagocytes.
To find whether the differences in the innate resistance of C57BL/10 mice (LDs0 5 x 105 bacteria) and CBA mice (LDs0 5 x 103 bacteria) to L. monocytogenes [12] is also expressed by a difference in the functioning of phagocytic cells, we performed a similar study with these bacteria. Table 2 Growth rate of S. typhimurium and /~ monocytogenes in the We found that the rates of phagocytosis and intracellular killing after in vivo or in vitro phagocytosis do not differ between the resident peritoneal macrophages, exudate peritoneal cells, and blood granulocytes of the two strains of mice [11] [12] [13] . However, the growth rates of L. monocytogenes in the liver and spleen of C57BL/10 mice were lower than the corresponding rates in CBA mice (Table 2 ) [12] . Thus, the results of these studies show that the difference in innate resistance to L. monocytogenes between C57BL/10 and CBA mice cannot be explained by differences in the functioning of phagocytic cells. There are, however, other differences between these mouse strains. For example, they differ in their capacity to form a cellular exudate at the site of inflammation [13] [14] [15] . C57BL/10 mice can form a significantly larger exudate of granulocytes and exudate macrophages than CBA mice. Similar differences were found in the magnitude of the increase of the population of blood monocytes during the response to an acute inflammation [15] ; this can be explained by the absence of a response by monocyte precursors in the bone marrow to FIM, which means that the rate of monocytopoiesis has not increased [15] .
The role of macrophages in acquired immunity
Because activation of macrophages occurs during an infection with BCG or L. monocytogenes, it was of interest to find whether the activated macrophages show a similar increase of bactericidal activity in CBA and C57BL/10 mouse strains. When these mice were infected by an intravenous injection of live BCG and challenged 21 days later with an intraperitoneal injection of PPD, the peritoneal macrophages phagocytosed opsonized L. monocytogenes effectively and at the same rate [16] . The rate of intracellular killing of L. monocytogenes by activated macrophages from both mouse strains proved to be greater by a factor of about 1.7-2.0 than that of the resident macrophages (Table 3 ). The findings made in in vivo studies [16] , i.e., absence of proliferation in the liver and spleen of BCG-infected mice, but instead a decrease in the number of bacteria, were consistent with the in vitro results showing increased bactericidal activity of activated macrophages [16] . 289 Table 3 Rates of intracellular killing of S. typhimurium (510) and L. monocytogenes by resident and activated macrophages of are not (Data from [16, 21] ). * * Significant increase in the rate of intracellular killing relative to the rate for resident macrophages.
However, BCG-PPD-activated macrophages did not kill S. typhimurium more rapidly than normal resident macrophages did (Table 3 ) [16] . Furthermore, killing of bacteria such as Staphylococcus aureus and Escherichia coli by these activated macrophages was not more efficient than that by resident macrophages [16] . In this connection it is important to note that the BCG-PPD-activated macrophages fulfilled two generally accepted criteria for macrophage activation [17] , i.e., inhibition of the intracellular replication of Toxoplasma gondii and enhanced oxidative metabolism, as reflected by the increased oxygen consumption and H202 release after stimulation of the cells with PMA [16] .
Macrophages from C57BL/10 and CBA mice collected 6 days after an intravenous injection of L. monocytogenes showed a similar response. The intracellular killing of L. monocytogenes by these activated peritoneal macrophages of both mouse strains was significantly more rapid than that by the resident macrophages (Table 3) . However, the rate of intracellular killing of S. typhimurium by Listeria-activated macrophages was similar to that found for resident macrophages [16] (Table 3) . These results show that both BCG-PPD-activated and Listeria-activated macrophages display enhanced microbicidal activity against some microorganisms, (e.g.L. monocytogenes and Toxoplasma gondii) but not all. These observations challenge the classic concept that activated macrophages express increased bactericidal activity against all species of micro-organisms.
Interferon-'~ is assumed to be the most important component of the T lymphocyte-derived lymphokines required for the induction of enhanced oxidative and toxoplasmastatic activity in macrophages [18] [19] [20] . This was found to hold for interferon-y-activated macrophages from C57BL/ 10 and CBA mice as well [21] . The percentage of Ia-positive macrophages and the intensity of Ia expression by such macrophages increased under these conditions (P.H. Nibbering, unpublished observations). Thus, these cells fulfilled various criteria for macrophage activation.
Resident macrophages activated with interferon-y either in vivo or in vitro did not, however, kill ingested Listeria monocytogenes at a higher rate than normal resident macrophages of C57BL/10 or CBA mice did (Table 2 ) [21] . This was recently confirmed by the results of a study performed with exudate macrophages from (C57BL/6 x DBA/2) F~ mice activated in vitro with interferon-,{ [22] . Furthermore, the growth of Listeria in the spleen and liver of C57BL/10 and CBA mice treated with interferon-7 was not retarded, since these bacteria proliferated at the same rate as those in normal mice [21] . The same was found for the rates of intracellular killing of S. typhimurium (Table 3 ) [21] . From these results it became evident that interferon-y, although adequate for the induction of some manifestations of macrophage activation, did not enable activated macrophages to kill bacteria more rapidly.
All of the in-vitro intracellular killing experiments referred to were performed in the presence of serum, because it is known that IgG and complement are obligatory for optimal stimulation of monocytes and macrophages to kill catalase-positive bacteria optimally [23, 24] . When we used a catalase-negative strain of L. monocytogenes (strain 1370, kindly provided by Dr. H. Hof, Wtirzburg, F.R.G.), the rate of intracellular killing after in vivo phagocytosis from rIFN-y-treated mice by macrophages was the same as the rate found for catalase-positive L. rnonocytogenes (strain EGD). In the absence of serum, however, catalase-negative L. monocytogenes is killed more rapidly by rIFN-7-treated macrophages than by normal macrophages (J.T. van Dissel and R. van Furth, unpublished).
DISCUSSION
The difference in the innate resistance of CBA and C57BL/10 mice to L. monocytogenes and S. typhimurium depends on various factors. For L. monocytogenes the bactericidal capacity of macrophages from both strains is similar. However, because C57BL/10 mice can mount a much larger cellular exudate at the site of infection than CBA mice, the former mice have the advantage, at equal bactericidal activity of the macrophages, that more phagocytes are available to eliminate L. monocytogenes. Activation of macrophages during an infection caused by BCG or L. monocytogenes leads to increased bactericidal activity against L. monoo, togenes and the absence of proliferation of these bacteria in the liver and spleen of both mouse strains. Interferon-y was, however, unable to enhance the bactericidal activity of macrophages either in vitro or in vivo. On these grounds it seems likely that the induction of increased bactericidal activity of macrophages requires not only interferon-7 but also other signals. Endotoxin is another such stimulus which, acting together with interferon-7, enhances the tumoricidal activity of macrophages [25] . However, endotoxin does not enhance the bactericidal activity of interferon-"~-treated macrophages [21] .
The difference in the innate resistance of mice to S. typhirnurium is expressed by differences in the rate of intracellular killing by resident macrophages and granulocytes and by differences in the proliferation of these bacteria in the spleen and liver of CBA and C57BL/10 mice. Activation of the macrophages by BCG, L. monocytogenes, or interferon--/ does not enhance the intracellular killing of S. typhimurium, which shows that these activated macrophages do not develop increased bactericidal activity against all species of microorganism.
A recent study of macrophages from mice infected with S. typhimurium (serotype 510) showed that these cells kill some, but not other, strains of S. typhimurium faster than macrophages from normal mice. Furthermore, the growth of some strains of S. typhimurium in the spleen and liver of S. typhimurium-infected mice slowed down or ceased (J. Langermans and R. van Furth, unpublished observations). These results also point to the specificity of the stimulus and effector functions with respect to macrophage activation.
